Patient Guide: Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 29 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04657822
Status: 🟢 Enrolling Now
Condition: Sickle Cell Disease
Phase: PHASE4

Where You Can Participate

This study is available at 29 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Washington D.C., District of Columbia
  • • Augusta, Georgia
  • • And 26 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study - Join Clinical Trial NCTNCT04657822

How to Join This Clinical Trial - NCTNCT04657822

Learn how to participate in this PHASE4 trial studying an investigational therapy for Sickle Cell Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Sickle Cell Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Sickle Cell Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04657822 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 29 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20010 - United States

Status: RECRUITING

Clinical Research Site

Augusta, Georgia 30912 - United States

Status: RECRUITING

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: COMPLETED

Clinical Research Site

Greenville, North Carolina 27858 - United States

Status: COMPLETED

Clinical Research Site

Philadelphia, Pennsylvania 19104-4399 - United States

Status: RECRUITING

Clinical Research Site

Fort Worth, Texas 76104 - United States

Status: COMPLETED

Clinical Research Site

Brussels, 1000 - Belgium

Status: COMPLETED

Clinical Research Site

Laken, 1020 - Belgium

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Liège, 4000 - Belgium

Status: ACTIVE_NOT_RECRUITING

And 19 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Sickle Cell Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships